BALPHARMA vs RELIANCE
Head-to-head DCF comparison · BAL PHARMA LTD. vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 4 of 4model metrics · not investment advice
BALPHARMA
BAL PHARMA LTD.
General/Diversified
₹77
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,353
Fairly Valued| Metric | BALPHARMA | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Fairly Valued |
| YieldIQ Score | 33/100 | 66/100 |
| Fair Value | ₹37 | ₹1,471 |
| Current Price | ₹77 | ₹1,353 |
| Margin of Safety | -52.5% | +8.7% |
| Moat | Narrow | Wide |
| Piotroski F-Score | 4/9 | 5/9 |
| ROE | — | — |
| Debt / Equity | 1.98 | 0.36 |
| EV / EBITDA | 11.2× | 12.8× |
| Market Cap | ₹123 Cr | ₹18.31 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.